fda compounding semaglutide crackdown news today 2025 New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our September 2, 2025: U.S. compounding

Mechanism of Action Mechanism of Action Copper Transport & "Redox Silencing" GHK-Cu acts as a carrier peptide with high affinity for copper(II) ions (pKa = 16.44)

I totally agree that the unethical compounders & outfits like HIMS which imho have grossly misled the public should be nailed, but there are compounders who are trying to follow FDA promulgations on stuff like this who get lumped in inappropriately imho

The LIRA-RENAL Trial (Once-Daily Liraglutide) The Efficacy and Safety of Liraglutide Versus Placebo as Add-on to Glucose-Lowering Therapy in Patients With Type 2 Diabetes and Moderate Renal Impairment (LIRA-RENAL) trial investigated the efficacy and safety of liraglutide as an add-on to existing glucose-lowering medications in people with inadequately controlled T2DM and moderate renal impairment (stage 3 CKD, eGFR 3059 ml/min/1.73 m 2 ) [48]

Samenstelling van Brawn Nutrition BPC-157: BPC-157 (500mcg)